Fledgling CDMO Lakes BioScience blueprints $490M antibody factory at ex-GlaxoSmithKline site

GlaxoSmithKline said last week that it would back out of antibiotic manufacturing in the U.K., slashing hundreds of jobs in the process. Now, an up-and-coming contract manufacturer is swooping in to build a new factory next door to one of GSK’ soon-to-be-closed plants.